Three doses of Pfizer’s COVID-19 vaccine offer strong protection for children younger than 5 ... third-shot data would be submitted this week. “The study suggests that a low, 3-microgram ...
WASHINGTON (AP) — Federal health officials said Sunday that kid-sized doses of Pfizer’s COVID ... shots are ready for the nation’s 18 million babies, toddlers and preschoolers. Kids under 5 ...
Between 2 and 3.5 inches of rain have fallen this week ... officials say they get a lot of questions from parents about COVID safety protocols. "We run through exactly how often we clean ...
Children that age would receive two shots of a larger 50 microgram ... vaccine advisors to consider the Pfizer/BioNTech COVID-19 vaccine for children under 5 years of age and requested additional ...
Independent reviewers confirmed a causal relationship between the first mRNA COVID-19 vaccines and myocarditis, and also ...
In some people, COVID-19 vaccines can lead to heart complications called myocarditis and pericarditis. Myocarditis is the swelling, also called inflammation, of the heart muscle. Pericarditis is the ...
Yes, the Pfizer/BioNTech and Moderna Covid-19 vaccines ... the potential risks under such an emergency situation. That being said, at present, there are still 5 important differences between ...
The Department of Health and Human Services and drugmakers Pfizer ... free Covid shots and treatments to uninsured Americans once those products move to the commercial market. Under the ...
It also unveiled plans for a $3.5 billion cost-cutting program, spread over two years, that will include a significant number of job cuts. Pfizer also ... an updated Covid shot, however, a ...
It will compare the shot against a licensed inactivated vaccine. The partners are hoping the same rapid development and deployment demonstrated with their COVID ... Pfizer. Worldwide, flu leads to ...
Stock futures rise modestly following a third straight closing record high for the S&P 500; Pfizer and Moderna rise after FDA clears third COVID shot ... futures were up 3 points and Nasdaq ...
The difference in Moderna and Pfizer ... 5%). For Pfizer/BioNTech, the numbers were lower: fatigue (3.8%) and headache (2%). Other biopharmaceutical companies are also in the race to develop Covid ...